EcoDrugPlus

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSUAMG00000015400
Gene Symbol: RIPK1
2 Cross references
197 Possible Orthologues:

Renin

Ensembl ID : ENSUAMG00000024963
Gene Symbol: REN
2 Cross references
218 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSUAMG00000023995
Gene Symbol: RET
2 Cross references
204 Possible Orthologues:

Retinoic Acid Receptor Alpha

Ensembl ID : ENSUAMG00000015094
Gene Symbol: RARA
2 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSUAMG00000010562
Gene Symbol: RARB
2 Cross references
450 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSUAMG00000003288
Gene Symbol: RARG
2 Cross references
445 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSUAMG00000020722
Gene Symbol: RXRA
2 Cross references
244 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSUAMG00000026918
Gene Symbol: RXRB
2 Cross references
234 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSUAMG00000014226
Gene Symbol: RPL10A
2 Cross references
167 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSUAMG00000008926
Gene Symbol: RPL11
2 Cross references
170 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSUAMG00000020363
Gene Symbol: RPL13
2 Cross references
267 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSUAMG00000013664
Gene Symbol: RPL14
1 Cross references
259 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).